JP2023515539A5 - - Google Patents

Info

Publication number
JP2023515539A5
JP2023515539A5 JP2022550963A JP2022550963A JP2023515539A5 JP 2023515539 A5 JP2023515539 A5 JP 2023515539A5 JP 2022550963 A JP2022550963 A JP 2022550963A JP 2022550963 A JP2022550963 A JP 2022550963A JP 2023515539 A5 JP2023515539 A5 JP 2023515539A5
Authority
JP
Japan
Prior art keywords
composition
amount
diclofenac
use according
daily
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022550963A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023515539A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NL2021/050125 external-priority patent/WO2021172987A1/en
Publication of JP2023515539A publication Critical patent/JP2023515539A/ja
Publication of JP2023515539A5 publication Critical patent/JP2023515539A5/ja
Priority to JP2026038922A priority Critical patent/JP2026116929A/ja
Pending legal-status Critical Current

Links

JP2022550963A 2020-02-27 2021-02-25 外用ジクロフェナク組成物及び方法 Pending JP2023515539A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026038922A JP2026116929A (ja) 2020-02-27 2026-03-11 外用ジクロフェナク組成物及び方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062982589P 2020-02-27 2020-02-27
US62/982,589 2020-02-27
PCT/NL2021/050125 WO2021172987A1 (en) 2020-02-27 2021-02-25 Topical diclofenac compositions and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026038922A Division JP2026116929A (ja) 2020-02-27 2026-03-11 外用ジクロフェナク組成物及び方法

Publications (2)

Publication Number Publication Date
JP2023515539A JP2023515539A (ja) 2023-04-13
JP2023515539A5 true JP2023515539A5 (cg-RX-API-DMAC7.html) 2024-03-01

Family

ID=74858737

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022550963A Pending JP2023515539A (ja) 2020-02-27 2021-02-25 外用ジクロフェナク組成物及び方法
JP2026038922A Pending JP2026116929A (ja) 2020-02-27 2026-03-11 外用ジクロフェナク組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026038922A Pending JP2026116929A (ja) 2020-02-27 2026-03-11 外用ジクロフェナク組成物及び方法

Country Status (9)

Country Link
US (1) US20230157979A1 (cg-RX-API-DMAC7.html)
EP (1) EP4110320A1 (cg-RX-API-DMAC7.html)
JP (2) JP2023515539A (cg-RX-API-DMAC7.html)
CN (1) CN115279360A (cg-RX-API-DMAC7.html)
AU (1) AU2021228521B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022016887A2 (cg-RX-API-DMAC7.html)
CA (1) CA3169241A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022010593A (cg-RX-API-DMAC7.html)
WO (1) WO2021172987A1 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2538856C (en) 2003-10-10 2010-06-29 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
US20120157536A1 (en) * 2010-12-20 2012-06-21 Polytherapeutics, Inc. Composition for transdermal administration of non-steroidal anti-flammatory drug
US9713590B2 (en) * 2011-07-28 2017-07-25 Cadila Healthcare Limited Method for treatment of pain and inflammation
BR112015000329A2 (pt) 2012-07-12 2017-06-27 Ferring Bv formulações de diclofenac
US20140113970A1 (en) * 2012-10-22 2014-04-24 Mallinckrodt LLC Covidien Dispensing system
US9468618B2 (en) * 2014-12-12 2016-10-18 Lupin Atlantis Holdings Sa Topical pharmaceutical gel composition of diclofenac sodium

Similar Documents

Publication Publication Date Title
EP4009944B1 (en) Topical formulations comprising cannabidiol, method of preparing the composition and use thereof
JP6434104B2 (ja) ジクロフェナク製剤
JP2015522049A5 (cg-RX-API-DMAC7.html)
EP3689328A1 (en) Compositions for relieving pain comprising malkangni oil and cypriol oil as active ingredients
CN101641103B (zh) 脱乙酰壳多糖在制备用于治疗指/趾甲炎症性疾病的药物中的用途
CN101972225A (zh) 一种含吡非尼酮的凝胶组合物
JP4359140B2 (ja) 異常な角質性物質を除去するための製剤
JP2024538277A (ja) スキンケアにおける使用に好適な組成物
WO2016181355A1 (en) Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity
RU2496476C1 (ru) Средство наружной терапии для больных атопическим дерматитом
CN112135621A (zh) 用于治疗阴道萎缩的组合物和方法
CN107441071B (zh) 一种芳姜黄酮在制备治疗和/或预防银屑病药物中的应用
US20050152993A1 (en) Composition for and method of treatment for skin ailments
JPH03291222A (ja) ジクロフェナック・ナトリウムを含有する局所用医薬組成物
AU2007200216A1 (en) Skin formulation usable as a therapeutic application for the treatment of general skin disorders and a method of preparation thereof
MX2023009424A (es) Composicion antitranspirante.
TWI911334B (zh) 外用組成物
US11672769B2 (en) Paraffin wax with CBD isolate
CN108969531A (zh) 聚乙二醇作为活性成分在制备银屑病治疗药物中的应用及其药物
WO2024042452A1 (en) Topical composition for pain relief
CN106943415B (zh) 一种预防和治疗皮肤瘙痒的外用药物组合物及其制备方法和用途
JP2023515539A (ja) 外用ジクロフェナク組成物及び方法
RU2706234C2 (ru) Применение гидроксида калия при лечении актинического кератоза
CN105434791A (zh) 一种治疗腋臭的凝胶剂的配方组成及制备方法
CN115887421A (zh) 一种复方糖皮质激素喷膜剂及其制备和应用